YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[An overturned pill bottle spills cash and medicinal capsules] Enrique Yocoyani Aguilar Licona/iStock via Getty Images The American Hospital Association has once again filed a lawsuit to halt a new pilot that tests a revised rebate model f…
Recent commentary around Surgery Partners (SGRY) has focused on softer unit sales over the past two years, a projected decline in sales over the next 12 months, and a relatively high forward P/E multiple. At a share price of US$13.89, Surg…
Surgery Partners has seen its share price fall sharply over recent years, which puts the spotlight squarely on whether the current valuation can be explained by the cash the business is expected to generate. With the stock recently closing…
1 Russell 2000 Stock with Competitive Advantages and 2 Facing Headwinds The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these com…
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as…
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q2 Earnings? Surgery Partners's 30.8% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $15.67 per share. This was partly thanks to its so…
Surgery Partners SGRY shares ended the last trading session 15.7% higher at $15.8. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.1% loss over…
Q2 Earnings Roundup: Encompass Health (NYSE:EHC) And The Rest Of The Outpatient & Specialty Care Segment As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2.…
Surgery Partners, Inc. BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced it has compl…
LifeStance Health Group (NASDAQ:LFST): Strongest Q2 Results from the Outpatient & Specialty Care Group Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at LifeStan…
Teresa DeLuca, a Director at Surgery Partners (NASDAQ:SGRY), executed a direct purchase of 11,250 shares of common stock on Aug. 18, 2026, according to a SEC Form 4 filing. Company snapshot Surgery Partners operates a nationwide network of…
3 Cash-Producing Stocks Walking a Fine Line Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunit…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Surgery Partners has seen its share price fall sharply over the past few years, yet the stock currently screens as cheap on…
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Tod…
Outpatient & Specialty Care Stocks Q2 Teardown: U.S. Physical Therapy (NYSE:USPH) Vs The Rest Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at U.S. Physical The…
Image source: The Motley Fool. DATE Monday, Aug. 10, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Financial Officer - David Doherty Chief Executive Officer - J. Eric Evans Chief Operating Officer - Justin Oppenheimer Full Conference Call T…
Community Health Systems, Inc. CYH is seeing improving operating volumes, along with continued progress in cost control, clinical quality, and patient experience. Recent divestitures are streamlining its portfolio while generating proceeds…
The Top 5 Analyst Questions From Surgery Partners's Q2 Earnings Call Surgery Partners' second quarter results were received positively by the market, with management highlighting that revenue and adjusted EBITDA came in ahead of expectatio…
1 of Wall Street's Favorite Stocks to Research Further and 2 We Avoid Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering that ana…
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) Wrapping up Q2 earnings, we look at the numbers and key takeaways for the outpatient & specialty care stocks, including Surgery Partners (NASDAQ:SGRY) and its…
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 2.7% year on year to $848.9 million. The co…
Nonfarm payrolls fell by a seasonally adjusted 23,000 in July, compared with a downwardly revised 20,000 in June. The Dow Jones consensus forecast had been looking for a gain of 83,000, as quoted on CNBC. The unemployment rate dipped to 4.…
Surgery Partners (SGRY) Q2 Earnings: What To Expect Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results this Monday before market hours. Here's what to expect. Surgery Partners beat analysts' revenue expec…
Surgeons operating ©Adobe Stock Images Surgery Partners, Inc. (NASDAQ:SGRY) shares slipped 0.71% in pre-market trading on Monday after the healthcare services company reported mixed second-quarter results, with revenue exceeding Wall Stree…
Surgery Partners (SGRY) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring item…
Last Friday, the three major Wall Street indexes closed a winning week. The Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average gained 5.2%, 3.6% and 3%, respectively. Wall Street's strong weekly performance was driven by re…
Surgery Partners (NASDAQ:SGRY) Beats Q2 CY2026 Sales Expectations Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 2.7% year on year to $848.9 million.…
* Surgery Partners press release [https://seekingalpha.com/pr/20612716-surgery-partners-inc-announces-second-quarter-2026-results-reaffirms-full-year-2026-guidance] (SGRY [https://seekingalpha.com/symbol/SGRY]): Q2 GAAP EPS of -$0.12 misse…
Major earnings expected before the bell on Monday include: * Barrick Mining Corporation (B [https://seekingalpha.com/symbol/B]) * Medical Properties Trust (MPT [https://seekingalpha.com/symbol/MPT]) * Seadrill Limited (SDRL [https://seekin…
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.2 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it…
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $1.6 per share a year ago. These figures are adjusted for non-recurring items. This…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Solventum (NYSE:SOLV) has appointed Neil Zieselman as Senior Vice P…
Spotting Winners: LifeStance Health Group (NASDAQ:LFST) And Outpatient & Specialty Care Stocks In Q1 Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let's have a look at LifeStance…
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it wil…
Surgery Partners SGRY shares rallied 5.3% in the last trading session to close at $16.41. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7…
3 Russell 2000 Stocks We Steer Clear Of Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these…